Gland Pharma Ltd. (GLAND) Share Price Hits Fresh 52-Week High at Rs 3,001.5

Gland Pharma Ltd. rose to Rs 2,994.3, up 0.92% today, after touching a fresh 52-week high of Rs 3,001.5. The company’s market capitalisation stands at Rs 47,752.07 crore.

Gland Pharma Ltd. Share Price was at Rs 2,994.3 on 14 August 2026 at 10:02 AM IST, up Rs 27.4 or 0.92% for the day, after touching a fresh 52-week high of Rs 3,001.5. With a market capitalisation of Rs 47,752.07 crore, the move has put Gland Pharma Ltd. Share Price firmly in focus across Stock Market Today searches and healthcare counters being tracked for momentum.

The verified data confirms the price event, but it does not establish a company-specific catalyst behind the move. Even without a stated trigger, the combination of a new one-year high, intraday strength and visible trading activity is enough to place the stock in today’s market conversation. For investors searching Gland Pharma Ltd. Stock News or Gland Pharma Ltd. Share Price Today, the key takeaway is simple: the stock has extended to a new yearly high while holding close to that level.

At Univest, such a move matters because a fresh 52-week peak often attracts attention from investors screening 52 Week High Stocks, Market Movers and breakout names. The next step is to separate price action from business quality, valuation context and sector positioning. That is where a fuller Gland Pharma Ltd. Fundamental Analysis becomes relevant.

Gland Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,994.3
Previous Close	Rs 2,966.9
Today's Change	+Rs 27.4 (+0.92%)
Day Open	Rs 2,989.95
Fresh 52-Week High	Rs 3,001.5
Day Low	Rs 2,951.7
Current Volume	10,563
Turnover	Rs 3.16 crore
Market Capitalisation	Rs 47,752.07 crore

Gland Pharma Ltd. (GLAND) traded at Rs 2,994.3. versus the previous close of Rs 2,966.9, a rise of 0.92%. The stock opened at Rs 2,989.95, reached Rs 3,001.5, touched Rs 2,951.7. Reported volume was 10,563.

Gland Pharma Ltd. Share Price Today reflects a measured but notable advance: the stock opened at Rs 2,989.95, moved between Rs 2,951.7 and Rs 3,001.5, and remained close to its fresh 52-week high during the session. That keeps the day’s move relevant even though the percentage gain was 0.92% rather than an outsized spike.

From the supplied data, Gland Pharma Ltd. Share Price rose from the previous close of Rs 2,966.9 to Rs 2,994.3, a gain of Rs 27.4. The stock opened slightly above the previous close at Rs 2,989.95, dipped to an intraday low of Rs 2,951.7 and then climbed to Rs 3,001.5, which is both the day’s high and the new 52-week high. That intraday range shows buyers were active enough to push the stock to a fresh 52-week peak even after an early pullback.

Trading activity also deserves attention. Current volume stood at 10,563 shares, while turnover was Rs 3.16 crore. For traders scanning Gland Pharma Ltd. Share Price Live, that means the stock did not just print a new high mechanically; it did so alongside measurable participation. In Share Market Today terms, the move places GLAND among Stocks in News because the market has now seen the stock trade at a new one-year high.

The broader reading is that price action remains constructive on the day, with the close-to-high structure more important than the modest absolute gain. Since the supplied dataset does not provide a confirmed company-specific trigger, investors following Gland Pharma Ltd. Share News should treat the event as a verified market update first and then assess whether fundamentals justify continued attention.

Gland Pharma Ltd. (GLAND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 47,752.07 crore
P/E Ratio	31.94x
P/B Ratio	0.47x
ROE	-2.89%
ROCE	-0.26%

Gland Pharma Ltd. was valued at a P/E ratio of 31.94x, a P/B ratio of 0.47x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.94x
Benchmark Median P/E	21.38x
Benchmark Average P/E	59.96x
Benchmark P/E Range	0x to 3,299.57x
Company P/B Ratio	0.47x
Benchmark Median P/B	1.95x
Company ROE	-2.89%
Benchmark Median ROE	10.92%
Company ROCE	-0.26%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 47,752.07 crore
Benchmark Median Market Cap	Rs 141.55 crore

Gland Pharma Ltd. (GLAND) is classified under sector: Healthcare.

Gland Pharma Ltd. (GLAND) has a P/E ratio of 31.94x, which is above the benchmark median of 21.38x, a difference of +49.39%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Gland Pharma Ltd. (GLAND) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Gland Pharma Ltd. (GLAND) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,995.34	31.94	0.47	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,836.87	69.35	10.97	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,644.55	34.7	7.15	-2.6	16.92
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,605.37	45.02	1.73	-0.78	8.31
Sai Parenteral's Ltd.	SAIPARENT	2,441.79	174.73	3.19	13.9	12.97

Gland Pharma Ltd. (GLAND) has a P/E ratio of 31.94x compared with the displayed peer median of 45.02x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 47,752.07 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Gland Pharma Ltd.

The stock is drawing attention because the market data, valuation context and peer positioning create a layered story rather than a single-factor move. For investors tracking Market News and Stock Updates on Univest, these are the verified reasons the counter is being watched today.

• Fresh price event: the stock touched Rs 3,001.5, a new 52-week high, and traded at Rs 2,994.3, up 0.92% or Rs 27.4 from Rs 2,966.9.
• Session structure: the day’s range of Rs 2,951.7 to Rs 3,001.5 shows the stock recovered from the intraday low and stayed near the top end.
• Trading activity: current volume was 10,563 shares with turnover of Rs 3.16 crore, keeping the move visible in daily market scans.
• Fundamental context: P/E is 31.94 and P/B is 0.47, while ROE is -2.89% and ROCE is -0.26%, creating a mixed Fundamental Analysis backdrop.
• Sector position: compared with 196 healthcare companies, the stock’s P/E is above the sector median of 21.38 but below the average of 59.96, while P/B is below both median and average.
• Peer lens: the company’s market capitalisation of Rs 47,752.07 crore is substantially above the supplied peers, but profitability trails several of them.

About Gland Pharma Ltd.

Based on the supplied dataset, Gland Pharma Ltd. is a listed healthcare company tracked under the symbol GLAND. The available company-level context in this article is limited to verified market data, valuation ratios and sector classification, which places the company within the Healthcare space for market comparison purposes.

That means investors looking at Gland Pharma Ltd. Stock News today are primarily evaluating the stock through price behaviour, market capitalisation, valuation and peer benchmarks rather than through a supplied business-segment or product breakdown. The peer basket provided for context includes companies from Pharmaceuticals & Drugs and Hospital & Healthcare Services, all within the broader Healthcare sector.

For practical monitoring, the most relevant current identifiers are the company name, the GLAND trading symbol, the fresh 52-week high event, and the market capitalisation of Rs 47,752.07 crore. On Univest, this company is therefore best tracked as a healthcare stock that has moved into fresh one-year-high territory and is now drawing added market attention.

Track Gland Pharma Ltd. Share Price on Univest

Use Gland Pharma Ltd. (GLAND) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors who want a structured Gland Pharma Ltd. Share Price Update can track the stock on Univest for live Share Price moves, 52-week levels, valuation ratios, peer comparison, market capitalisation and broader market insights. That helps place daily price action alongside deeper Stock Analysis rather than viewing the move in isolation.

Univest also helps users follow Gland Pharma Ltd. Share Price Today in the context of sector benchmarks, Healthcare trends and comparative metrics such as P/E, P/B, ROE and ROCE. For a stock that has just marked a fresh yearly high, that kind of side-by-side context can be useful for monitoring what the market is pricing in and what the verified numbers currently show.

Frequently Asked Questions

What is Gland Pharma Ltd. Share Price today?

Ans. Gland Pharma Ltd. Share Price today was Rs 2,994.3 at 10:02 AM IST on 14 August 2026. The stock was up Rs 27.4, or 0.92%, from the previous close of Rs 2,966.9.

Did Gland Pharma Ltd. hit a fresh 52-week high today?

Ans. Yes, Gland Pharma Ltd. touched a fresh 52-week high of Rs 3,001.5 during the session. It then traded at Rs 2,994.3, keeping the stock close to its new one-year high in live market action.

Why is Gland Pharma Ltd. Share Price in focus today?

Ans. The stock is in focus because it registered a fresh 52-week high, rose 0.92% on the day and generated turnover of Rs 3.16 crore. The supplied data confirms the price event but does not establish a company-specific catalyst.

What was the day range for Gland Pharma Ltd. shares?

Ans. On 14 August 2026, Gland Pharma Ltd. opened at Rs 2,989.95, fell to Rs 2,951.7 and rose to Rs 3,001.5. That intraday range shows the stock recovered from the low and tested a new yearly peak.

What is the market capitalisation of Gland Pharma Ltd.?

Ans. Gland Pharma Ltd. had a market capitalisation of Rs 47,752.07 crore in the supplied data. That is far above the healthcare benchmark median of Rs 141.55 crore and average of Rs 465.17 crore shown in the sector snapshot.

How is Gland Pharma Ltd. valued on P/E and P/B?

Ans. The stock is valued at a P/E ratio of 31.94 and a P/B ratio of 0.47. Its P/E is above the healthcare median of 21.38, while its P/B is below the sector median of 1.95.

What do ROE and ROCE indicate for Gland Pharma Ltd.?

Ans. Gland Pharma Ltd. shows ROE of -2.89% and ROCE of -0.26% in the supplied dataset. Both figures are below the healthcare sector medians of 10.92% and 13.29%, indicating weaker reported return metrics versus the benchmark.

How does Gland Pharma Ltd. compare with its supplied peers?

Ans. Gland Pharma Ltd. has a market capitalisation of Rs 47,752.07 crore, much larger than supplied peers such as Beta Drugs at Rs 2,836.87 crore and Sai Parenteral's at Rs 2,441.79 crore. Profitability, however, trails several peers.

What volume and turnover were recorded in Gland Pharma Ltd. today?

Ans. The supplied market data shows current volume of 10,563 shares and turnover of Rs 3.16 crore. Those figures indicate visible participation on the day when the stock touched its fresh 52-week high of Rs 3,001.5.

Should investors track Gland Pharma Ltd. after this one-year high?

Ans. Investors may monitor whether Gland Pharma Ltd. holds near its fresh 52-week peak, while also tracking valuation and profitability metrics. The stock combines a large market cap with mixed return ratios and a notable sector valuation backdrop.